SOLS Stock Analysis: Buy, Sell, or Hold?
$56.98
0.66 (1.17%)
â˛
5d:
+1.73%
30d:
-7.69%
90d:
-28.94%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 29, 2026
26d
Get Alerted When SOLS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SOLS is fairly priced but lacks strong directional signals. At -9.1% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SOLS is fairly priced but lacks strong directional signals. At -9.1% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$123.22
Based on 10.4% avg growth
INTRINSIC VALUE TODAY
$76.51
25.5% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SOLS is currently trading at $56.98, which is considered slightly low relative to its 30-day fair value range of $56.14 to $61.87. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.9) compared to its historical average (22.5). Remarkably, the market is currently pricing in an annual earnings decline of 9.1% over the next few years. This pessimistic expectation contrasts with the company's recent 22.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SOLS is in a strong downtrend. Immediate support is located at $54.78, while resistance sits at $59.42.
Market Sentiment: SOLS scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $80.25 (+40.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SOLS is in a strong downtrend. Immediate support is located at $54.78, while resistance sits at $59.42.
Market Sentiment: SOLS scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $80.25 (+40.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$56.14 -
$61.87
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.8% below Wall St target ($80.25)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$56.14 -
$61.87
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$54.79
Resistance Level
$59.42
Current Trend
Strong Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.95
Wall Street Target
$80.25
(+40.8%)
Revenue Growth (YoY)
11.1%
Earnings Growth (YoY)
22.8%
Profit Margin
5.1%
Valuation Discount vs History
-9.1% cheaper
PE vs Historical
17.0 vs 22.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.1%
(market-implied from PE analysis)
1-Year Target
$51.79
(-9%)
2-Year Target
$47.08
(-17%)
3-Year Target
$42.80
(-25%)
3-Yr Target (if PE normalizes)
(PE: 17â23)
$56.79
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 16.7%)
$108.90
(+91%)
Base:
(SPY PE: 17.0, Growth: 16.7%)
$90.51
(+59%)
Bear:
(PE: 14.4, Growth: 16.7%)
$76.93
(+35%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (42x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 42.35 | Current EPS (TTM): $1.33
Bull Case
$123.90
(+118%)
Analyst growth 100.0%, PE expands to 46.6
Base Case
$112.64
(+98%)
Market implied 100.0%, PE stable at 42.4
Bear Case
$38.30
(-33%)
Severe decline -20.0%, PE contracts to 36.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.0 to 22.5
Stabilization Target:
$75.62
(+32.7%)
PE Expansion Potential:
+32.7%
Share & Embed Analysis
Last updated: October 02, 2026 3:54 AM ET
Data refreshes hourly during market hours. Next update: 4:54 AM
Data refreshes hourly during market hours. Next update: 4:54 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOLS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
BUY
28 analysts |
$543 | 59 HOLD |
|
ECL
Ecolab Inc |
STRONG BUY
27 analysts |
$325 | 58 HOLD |
|
SHW
Sherwin-Williams Co |
BUY
28 analysts |
$389 | 54 HOLD |
|
ALB
Albemarle Corp |
HOLD
28 analysts |
$172 | 57 HOLD |
|
APD
Air Products and ChemicaâĻ |
BUY
24 analysts |
$345 | 43 HOLD |